85 related articles for article (PubMed ID: 8167104)
1. Culture of tissue-cyst forming strain of Toxoplasma gondii and the effect of cyclic AMP and pyrimidine salvage inhibitors.
Choi WY; Park SK; Nam HW; Kim DJ
Korean J Parasitol; 1994 Mar; 32(1):19-26. PubMed ID: 8167104
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii Cyclic AMP-Dependent Protein Kinase Subunit 3 Is Involved in the Switch from Tachyzoite to Bradyzoite Development.
Sugi T; Ma YF; Tomita T; Murakoshi F; Eaton MS; Yakubu R; Han B; Tu V; Kato K; Kawazu S; Gupta N; Suvorova ES; White MW; Kim K; Weiss LM
mBio; 2016 May; 7(3):. PubMed ID: 27247232
[TBL] [Abstract][Full Text] [Related]
3. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
Portes JA; De Souza W
Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
[TBL] [Abstract][Full Text] [Related]
4. Unexpected oocyst shedding by cats fed Toxoplasma gondii tachyzoites: in vivo stage conversion and strain variation.
Dubey JP
Vet Parasitol; 2005 Nov; 133(4):289-98. PubMed ID: 16024176
[TBL] [Abstract][Full Text] [Related]
5. A cell culture system for study of the development of Toxoplasma gondii bradyzoites.
Weiss LM; Laplace D; Takvorian PM; Tanowitz HB; Cali A; Wittner M
J Eukaryot Microbiol; 1995; 42(2):150-7. PubMed ID: 7757057
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotide signaling in Toxoplasma gondii bradyzoite differentiation.
Kirkman LA; Weiss LM; Kim K
Infect Immun; 2001 Jan; 69(1):148-53. PubMed ID: 11119500
[TBL] [Abstract][Full Text] [Related]
7. Effects of pyrimidine salvage inhibitors on uracil incorporation of Toxoplasma gondii.
Youn JH; Nam HW; Kim DJ; Choi WY
Kisaengchunghak Chapchi; 1990 Jun; 28(2):79-84. PubMed ID: 2271504
[TBL] [Abstract][Full Text] [Related]
8. Structural changes of Toxoplasma gondii bradyzoites and cysts following therapy with sulfamethoxypyrazine-pyrimethamine: studies by light and electron microscopy. Consequences for chemotherapy.
Werner H; Matuschka FR; Brandenburg I
Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):240-53. PubMed ID: 44617
[TBL] [Abstract][Full Text] [Related]
9. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.
Bohne W; Heesemann J; Gross U
Infect Immun; 1994 May; 62(5):1761-7. PubMed ID: 8168938
[TBL] [Abstract][Full Text] [Related]
10. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibitory effects of bovine lactoferrin to Toxoplasma gondii parasites in murine somatic cells.
Tanaka T; Omata Y; Saito A; Shimazaki K; Igarashi I; Suzuki N
J Vet Med Sci; 1996 Jan; 58(1):61-5. PubMed ID: 8645758
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibitory effect of bovine lactoferrin to Toxoplasma gondii tachyzoites in murine macrophages: tyrosine phosphorylation in murine macrophages induced by bovine lactoferrin.
Tanaka T; Omata Y; Isamida T; Saito A; Shimazaki K; Yamauchi K; Suzuki N
J Vet Med Sci; 1998 Mar; 60(3):369-71. PubMed ID: 9560789
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii cyst wall formation in activated bone marrow-derived macrophages and bradyzoite conditions.
Tobin C; Pollard A; Knoll L
J Vis Exp; 2010 Aug; (42):. PubMed ID: 20736916
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii infection in the peritoneal macrophages of rats treated with glucocorticoids.
Wang T; Gao JM; Yi SQ; Geng GQ; Gao XJ; Shen JL; Lu FL; Wen YZ; Hide G; Lun ZR
Parasitol Res; 2014 Jan; 113(1):351-8. PubMed ID: 24248630
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
16. Primary culture of skeletal muscle cells as a model for studies of Toxoplasma gondii cystogenesis.
Guimarães EV; de Carvalho L; Barbosa HS
J Parasitol; 2008 Feb; 94(1):72-83. PubMed ID: 18372624
[TBL] [Abstract][Full Text] [Related]
17. Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with a cystogenic ME49 strain of Toxoplasma gondii.
El-Zawawy LA; El-Said D; Mossallam SF; Ramadan HS; Younis SS
Acta Trop; 2015 Jan; 141(Pt A):103-11. PubMed ID: 25305510
[TBL] [Abstract][Full Text] [Related]
18. [Effect of IL-6 on the multiplication of Toxoplasma gondii].
Fang Y; Tan Y; Zhang Y; Li J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(2):106-8. PubMed ID: 12563793
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolic acid induces differentiation of Toxoplasma gondii RH strain tachyzoites into bradyzoites and formation of cyst-like structure in vitro.
Castro-Elizalde KN; Hernández-Contreras P; Ramírez-Flores CJ; González-Pozos S; Gómez de León CT; Mondragón-Castelán M; Mondragón-Flores R
Parasitol Res; 2018 Feb; 117(2):547-563. PubMed ID: 29308550
[TBL] [Abstract][Full Text] [Related]
20. Use of prednisolone to aid propagation of Toxoplasma gondii in mice.
Puvanesuaran VR; Nowroji K; Sreenivasan S; Noordin R; Balakrishnan V
Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):1028-32. PubMed ID: 22913152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
